{"id":"https://openalex.org/W4400108909","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.4527","title":"Changes in treatment (Rx) patterns and attrition rates in patients (pts) with metastatic clear cell renal cell carcinoma (mccRCC).","display_name":"Changes in treatment (Rx) patterns and attrition rates in patients (pts) with metastatic clear cell renal cell carcinoma (mccRCC).","alternate_titles":[],"publication_year":2024,"publication_date":"2024-06-01","ids":{"openalex":"https://openalex.org/W4400108909","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.4527"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2024.42.16_suppl.4527","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.4527","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1200/jco.2024.42.16_suppl.4527","pdf_url":"https://ascopubs.org/doi/pdf/10.1200/JCO.2024.42.16_suppl.4527","source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4400108909"],"child_works_count":0,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://ascopubs.org/doi/pdf/10.1200/JCO.2024.42.16_suppl.4527","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5031760297","display_name":"Gliceida Galarza Fortuna","orcid":"https://orcid.org/0000-0002-1084-953X","observed_orcids":["https://orcid.org/0000-0002-1084-953X"]},"institutions":[{"id":"https://openalex.org/I2801159745","display_name":"Huntsman Cancer Institute","ror":"https://ror.org/03v7tx966","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801159745","https://openalex.org/I4210148268"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gliceida Galarza Fortuna","raw_affiliation_strings":["Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT","institution_ids":["https://openalex.org/I2801159745"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022549511","display_name":"Yeonjung Jo","orcid":"https://orcid.org/0000-0002-1630-2957","observed_orcids":["https://orcid.org/0000-0002-1630-2957"]},"institutions":[{"id":"https://openalex.org/I2801159745","display_name":"Huntsman Cancer Institute","ror":"https://ror.org/03v7tx966","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801159745","https://openalex.org/I4210148268"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yeonjung Jo","raw_affiliation_strings":["Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT","institution_ids":["https://openalex.org/I2801159745"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069934601","display_name":"Chadi Hage Chehade","orcid":"https://orcid.org/0009-0008-6735-5777","observed_orcids":["https://orcid.org/0009-0008-6735-5777"]},"institutions":[{"id":"https://openalex.org/I2801159745","display_name":"Huntsman Cancer Institute","ror":"https://ror.org/03v7tx966","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801159745","https://openalex.org/I4210148268"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chadi Hage Chehade","raw_affiliation_strings":["Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT","institution_ids":["https://openalex.org/I2801159745"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5093539193","display_name":"Arshit Narang","orcid":"https://orcid.org/0009-0003-0993-1805","observed_orcids":["https://orcid.org/0009-0003-0993-1805"]},"institutions":[{"id":"https://openalex.org/I2801159745","display_name":"Huntsman Cancer Institute","ror":"https://ror.org/03v7tx966","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801159745","https://openalex.org/I4210148268"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Arshit Narang","raw_affiliation_strings":["Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT","institution_ids":["https://openalex.org/I2801159745"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040276771","display_name":"Georges Gebrael","orcid":"https://orcid.org/0000-0002-4085-6415","observed_orcids":["https://orcid.org/0000-0002-4085-6415","https://orcid.org/0009-0000-5807-5468"]},"institutions":[{"id":"https://openalex.org/I2801159745","display_name":"Huntsman Cancer Institute","ror":"https://ror.org/03v7tx966","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801159745","https://openalex.org/I4210148268"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Georges Gebrael","raw_affiliation_strings":["Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT","institution_ids":["https://openalex.org/I2801159745"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006238975","display_name":"Vinay Mathew Thomas","orcid":"https://orcid.org/0000-0001-9916-730X","observed_orcids":["https://orcid.org/0000-0001-9916-730X"]},"institutions":[{"id":"https://openalex.org/I2801159745","display_name":"Huntsman Cancer Institute","ror":"https://ror.org/03v7tx966","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801159745","https://openalex.org/I4210148268"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vinay Mathew Thomas","raw_affiliation_strings":["Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT","institution_ids":["https://openalex.org/I2801159745"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065967338","display_name":"Beverly Chigarira","orcid":"https://orcid.org/0009-0001-6253-2374","observed_orcids":["https://orcid.org/0009-0001-6253-2374"]},"institutions":[{"id":"https://openalex.org/I2801159745","display_name":"Huntsman Cancer Institute","ror":"https://ror.org/03v7tx966","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801159745","https://openalex.org/I4210148268"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Beverly Chigarira","raw_affiliation_strings":["Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT","institution_ids":["https://openalex.org/I2801159745"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Ethan Anderson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]},{"id":"https://openalex.org/I2801159745","display_name":"Huntsman Cancer Institute","ror":"https://ror.org/03v7tx966","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801159745","https://openalex.org/I4210148268"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ethan Anderson","raw_affiliation_strings":["University of Utah/Huntsman Cancer Institute, Salt Lake City, UT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Utah/Huntsman Cancer Institute, Salt Lake City, UT","institution_ids":["https://openalex.org/I223532165","https://openalex.org/I2801159745"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017585615","display_name":"Archisman Mazumder","orcid":"https://orcid.org/0000-0001-9150-8800","observed_orcids":["https://orcid.org/0000-0001-9150-8800"]},"institutions":[{"id":"https://openalex.org/I2801159745","display_name":"Huntsman Cancer Institute","ror":"https://ror.org/03v7tx966","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801159745","https://openalex.org/I4210148268"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Archisman Mazumder","raw_affiliation_strings":["Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT","institution_ids":["https://openalex.org/I2801159745"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035158962","display_name":"Zeynep \u0130rem \u00d6zay","orcid":"https://orcid.org/0000-0002-4827-9042","observed_orcids":["https://orcid.org/0000-0002-4827-9042"]},"institutions":[{"id":"https://openalex.org/I95634034","display_name":"Gazi University","ror":"https://ror.org/054xkpr46","country_code":"TR","type":"education","lineage":["https://openalex.org/I95634034"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Zeynep Irem Ozay","raw_affiliation_strings":["Gazi University Faculty of Medicine, Ankara, Turkey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gazi University Faculty of Medicine, Ankara, Turkey","institution_ids":["https://openalex.org/I95634034"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100763587","display_name":"Neeraj Agarwal","orcid":"https://orcid.org/0000-0003-1076-0428","observed_orcids":["https://orcid.org/0000-0003-1076-0428","https://orcid.org/0000-0001-6574-8499"]},"institutions":[{"id":"https://openalex.org/I2801159745","display_name":"Huntsman Cancer Institute","ror":"https://ror.org/03v7tx966","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801159745","https://openalex.org/I4210148268"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Neeraj Agarwal","raw_affiliation_strings":["Huntsman Cancer Institute, Salt Lake City, UT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Huntsman Cancer Institute, Salt Lake City, UT","institution_ids":["https://openalex.org/I2801159745"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022744341","display_name":"Benjamin Louis Maughan","orcid":"https://orcid.org/0000-0002-0010-8551","observed_orcids":["https://orcid.org/0000-0002-0010-8551"]},"institutions":[{"id":"https://openalex.org/I2801159745","display_name":"Huntsman Cancer Institute","ror":"https://ror.org/03v7tx966","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801159745","https://openalex.org/I4210148268"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Benjamin L. Maughan","raw_affiliation_strings":["Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT","institution_ids":["https://openalex.org/I2801159745"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5034103357","display_name":"Umang Swami","orcid":"https://orcid.org/0000-0003-3518-0411","observed_orcids":["https://orcid.org/0000-0003-3518-0411"]},"institutions":[{"id":"https://openalex.org/I2801159745","display_name":"Huntsman Cancer Institute","ror":"https://ror.org/03v7tx966","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801159745","https://openalex.org/I4210148268"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Umang Swami","raw_affiliation_strings":["Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT","institution_ids":["https://openalex.org/I2801159745"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"42","issue":"16_suppl","first_page":"4527","last_page":"4527"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.003100000089034438,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metastatic-clear-cell-renal-cell-carcinoma","display_name":"metastatic clear cell renal cell carcinoma","score":0.9980000257492065},{"id":"https://openalex.org/keywords/treatment-patterns","display_name":"treatment patterns","score":0.7829999923706055},{"id":"https://openalex.org/keywords/attrition-rates","display_name":"attrition rates","score":0.6990000009536743},{"id":"https://openalex.org/keywords/pd-1-inhibitors","display_name":"PD-1 inhibitors","score":0.902999997138977},{"id":"https://openalex.org/keywords/ctla-4-inhibitors","display_name":"CTLA-4 inhibitors","score":0.8640000224113464},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.6660000085830688},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.8809999823570251},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.8360000252723694},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.6650000214576721},{"id":"https://openalex.org/keywords/real-world-data","display_name":"real-world data","score":0.6629999876022339},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.5659999847412109},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.5849999785423279},{"id":"https://openalex.org/keywords/treatment-de-escalation","display_name":"treatment de-escalation","score":0.4950000047683716},{"id":"https://openalex.org/keywords/immune-related-adverse-events","display_name":"immune-related adverse events","score":0.43700000643730164}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.909195065498352},{"id":"https://openalex.org/C2777472916","wikidata":"https://www.wikidata.org/wiki/Q1164529","display_name":"Renal cell carcinoma","level":2,"score":0.7713550925254822},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5125300884246826},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.509199321269989},{"id":"https://openalex.org/C2778560582","wikidata":"https://www.wikidata.org/wiki/Q18347894","display_name":"Clear cell","level":3,"score":0.4634658396244049},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.45654985308647156},{"id":"https://openalex.org/C2781278892","wikidata":"https://www.wikidata.org/wiki/Q18556340","display_name":"Clear cell renal cell carcinoma","level":3,"score":0.44182801246643066},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3918301463127136},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.3242719769477844},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2024.42.16_suppl.4527","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.4527","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1200/jco.2024.42.16_suppl.4527","pdf_url":"https://ascopubs.org/doi/pdf/10.1200/JCO.2024.42.16_suppl.4527","source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1200/jco.2024.42.16_suppl.4527","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.4527","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1200/jco.2024.42.16_suppl.4527","pdf_url":"https://ascopubs.org/doi/pdf/10.1200/JCO.2024.42.16_suppl.4527","source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4400108909.pdf","grobid_xml":"https://content.openalex.org/works/W4400108909.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4408661714","https://openalex.org/W7133223918","https://openalex.org/W4414992735","https://openalex.org/W2281421996","https://openalex.org/W4404851215","https://openalex.org/W3123698885","https://openalex.org/W7133243569","https://openalex.org/W2954531804","https://openalex.org/W2948873563","https://openalex.org/W2528048907"],"abstract_inverted_index":{"4527":[0],"Background:":[1],"Rx":[2,43,97,110,131,137,148,190,198,223,282,297,375],"landscape":[3],"of":[4,12,100,119,121,202,235,311,321,347,356],"mccRCC":[5,333],"has":[6],"evolved":[7],"rapidly":[8],"with":[9,23,87,98,344],"the":[10,65,74,116,180,195,200,220,231,245,264,285,306,309,331,340,345],"approval":[11,52,117],"antibodies":[13],"directed":[14],"against":[15],"programmed":[16],"cell":[17,89],"death":[18],"protein-1":[19],"(PD-1)":[20],"in":[21,59,64,194,224,263,284,308,330,335,339,351,381,389],"combination":[22,213,328],"cytotoxic":[24],"T-lymphocyte-associated":[25],"protein":[26],"4":[27],"(CTLA4)":[28],"or":[29,162,362],"vascular":[30],"endothelial":[31],"growth":[32],"factor":[33],"receptor":[34],"tyrosine":[35],"kinase":[36],"(TKI)":[37],"inhibitors.":[38],"However,":[39],"real-world":[40,62,337],"data":[41],"on":[42,115],"trends":[44,191],"and":[45,48,134,186,240,249,253,277,298,313,384],"attrition":[46],"before":[47,132],"after":[49,138,147,227,260,373],"PD-1":[50,212,348],"inhibitor":[51],"are":[53,192],"lacking.":[54],"Herein,":[55],"we":[56],"analyze":[57],"them":[58],"a":[60,318,353],"large":[61],"cohort":[63],"United":[66,341],"States.":[67,342],"Methods:":[68],"This":[69],"IRB-approved":[70],"retrospective":[71],"study":[72],"used":[73],"nationwide":[75],"Flatiron":[76],"Health":[77],"electronic":[78],"health":[79],"record":[80],"(EHR)-derived":[81],"de-identified":[82],"database.":[83],"Inclusion:":[84],"Metastatic":[85],"RCC":[86],"clear":[88],"histology":[90],"diagnosed":[91],"between":[92],"1/1/2011":[93],"to":[94,150,211],"1/31/2022":[95],"receiving":[96],"opportunity":[99],"at":[101,144,368],"least":[102],"1":[103,145,369],"year":[104,146,370],"follow":[105],"up.":[106],"Exclusion:":[107],"Pts":[108],"needing":[109],"for":[111,199],"\u22652":[112],"malignancies.":[113],"Based":[114],"date":[118],"PD-1+CTLA4":[120],"4/16/18,":[122],"pts":[123,152,185,203,268,289,357],"were":[124,155,279,300,363],"separated":[125],"into":[126],"2":[127],"groups:":[128],"b2018":[129,210,232,265],"(1L":[130,136],"4/16/2018)":[133],"a2018":[135,215,246,286],"4/16/18).":[139],"Landmark":[140],"analysis":[141,167,259,372],"was":[142,168],"performed":[143],"discontinuation":[149],"identify":[151],"who":[153],"died,":[154],"alive":[156,280,301,364],"but":[157],"did":[158,324],"not":[159,325],"need":[160,379],"Rx,":[161,239,271,276,292],"starting":[163],"next-line":[164],"Rx.":[165,303],"All":[166],"done":[169],"using":[170],"R":[171],"version":[172],"4.2.3.":[173],"Results:":[174],"Of":[175],"12707":[176],"pts,":[177],"7923":[178],"met":[179],"eligibility":[181],"criteria":[182],"(b2018:":[183],"4561":[184],"a2018:":[187],"3362":[188],"pts).":[189],"summarized":[193],"table.":[196],"1L":[197,228,261,332,374],"majority":[201],"changed":[204],"from":[205],"TKI":[206,217],"monotherapy":[207],"(mono;":[208],"79%)":[209],"therapies":[214],"(58%).":[216],"mono":[218],"remained":[219],"most":[221],"common":[222],"both":[225],"groups":[226],"(Table).":[229],"In":[230,244],"cohort,":[233,247],"58%":[234,267],"patients":[236,322],"received":[237,242,251,269,290],"2L":[238,252],"32%":[241,299],"3L.":[243],"42%":[248,288],"16%":[250],"3L,":[254],"respectively.":[255],"At":[256],"1-year":[257],"landmark":[258,371],"discontinuation:":[262],"group,":[266,287],"next":[270,291],"30%":[272],"died":[273,294],"without":[274,281,295,302,365],"further":[275,296,366],"12%":[278],"while":[283],"26%":[293],"Conclusions:":[304],"Despite":[305],"increase":[307],"utilization":[310],"PD-1+CTLA-4":[312],"PD-1+TKI":[314],"regimens":[315,329],"since":[316],"2018,":[317],"significant":[319],"number":[320],"still":[323],"receive":[326],"novel":[327],"setting":[334],"this":[336],"population":[338],"Furthermore,":[343],"uptake":[346],"based":[349],"combinations":[350],"1L,":[352],"higher":[354],"proportion":[355],"experience":[358],"treatment":[359],"free":[360],"interval":[361],"therapy":[367],"discontinuation.":[376],"These":[377],"findings":[378],"validation":[380],"other":[382],"datasets":[383],"can":[385],"help":[386],"patient":[387],"counseling":[388],"clinics.[Table:":[390],"see":[391],"text]":[392]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4400108909","counts_by_year":[{"year":2025,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2024-06-29T00:00:00"}
